Effects of M274773, a neurokinin-2 receptor antagonist, on bladder function in chronically spinalized rats - PubMed (original) (raw)

Effects of M274773, a neurokinin-2 receptor antagonist, on bladder function in chronically spinalized rats

Aly M Abdel-Karim et al. J Urol. 2005 Oct.

Abstract

Purpose: Increased afferent nerve activity may have an important role in the pathogenesis of neurogenic detrusor overactivity. We tested the efficacy of the neuokinin-2 receptor antagonist M274773 ((S)-N-[2-(3,4-Dichlorophenyl)-4-[4-(2-oxoperhydro-pyrimidin-l-yl) piperidino]butyl]-N-methylbenzamide dihydrochloride) on neurogenic detrusor overactivity after spinal cord injury in rats.

Materials and methods: Included in this study were 48 adult Sprague-Dawley rats (Charles River, Montreal, Quebec, Canada). Six animals served as normal controls, while 32 underwent spinal cord transection at the 10th thoracic vertebra. Two weeks after spinal cord injury 6 animals underwent filling cystometrography to confirm neurogenic detrusor overactivity, while another 12 served as paraplegic controls. The remaining 24 paraplegic animals were used to test the drug and they were divided into 2 equal groups of 12. Group 1 received the drug at a dose of 0.3 mg/kg daily, while group 2 received a dose of 0.6 mg/kg daily. Each paraplegic control and treatment group was further subdivided into 2 subgroups of 6 rats each. In subgroup 1 filling cystometrography was done 3 weeks after spinal cord injury, while in subgroup 2 it was done 4 weeks after spinal cord injury.

Results: Three weeks after spinal cord injury neurogenic detrusor overactivity developed in all paraplegic control animals with a mean bladder capacity +/- SD of 0.7 +/- 0.2 ml and a mean voiding pressure of 59 +/- 14.2 cm H2O. Neurogenic detrusor overactivity resolved in 50% and 83% of the animals that received M274773 for 1 week at doses of 0.3 and 0.6 mg/kg daily, respectively. Mean cystometric bladder capacity was 1.2 +/- 0.5 vs 1.3 +/- 0.4 ml and mean voiding pressure was 46.1 +/- 10.8 vs 40 +/- 9.9 cm H2O in animals that received 0.3 vs 0.6 mg/kg daily, respectively. The drug produced better urodynamic results when given for 2 weeks rather than 1 week.

Conclusions: M274773 is effective for neurogenic detrusor overactivity after spinal cord injury in the rat. It may provide an alternative clinical treatment option for neurogenic detrusor overactivity and urgency/frequency syndrome. This new neurokinin-2 selective antagonist has time and dose response effects, which further suggests the potential for clinical application.

PubMed Disclaimer

Cited by

Neural control of the lower urinary tract.
de Groat WC, Griffiths D, Yoshimura N. de Groat WC, et al. Compr Physiol. 2015 Jan;5(1):327-96. doi: 10.1002/cphy.c130056. Compr Physiol. 2015. PMID: 25589273 Free PMC article. Review.
Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease.
Steinhoff MS, von Mentzer B, Geppetti P, Pothoulakis C, Bunnett NW. Steinhoff MS, et al. Physiol Rev. 2014 Jan;94(1):265-301. doi: 10.1152/physrev.00031.2013. Physiol Rev. 2014. PMID: 24382888 Free PMC article. Review.
Effect of electroacupuncture on cyclic adenosine monophosphate-protein kinase A-vanillic acid receptor subtype 1 of the transient receptor potential/PLK-protein kinase C-vanillic acid receptor subtype 1 of the transient receptor potential pathway based on RNA-seq analysis in prostate tissue in rats with chronic prostatitis/chronic pelvic pain syndrome.
Wu XL, Cheng K, Xu C, Chai YM, Yap TH, Yang ZW, Sun QH, Tan Y, Zhang JN, Chen W, Qiu XH, Yang XY, Li N. Wu XL, et al. Front Neurosci. 2022 Aug 24;16:938200. doi: 10.3389/fnins.2022.938200. eCollection 2022. Front Neurosci. 2022. PMID: 36090261 Free PMC article.

Effects of M274773, a neurokinin-2 receptor antagonist, on bladder function in chronically spinalized rats - PubMed (original) (raw)